More work needs to be done to stratify the ME/CFS patients into different phenotypes or categories, as this is a heterogenous group of patients
Summary Pulling the new reports together, there is further momentum and excitement building for GLP-1 drug expanded use beyond diabetes and obesity
Such approaches have been aided by rapid technological advances in analytical omic platforms leading to a recent proliferation in studies seeking to define the macromolecular signatures (e.g
Note that intravenous injections should be performed by or under the supervision of a veterinary surgeon
Linetzky B, Sattar N, Verma S, Krumholz H , Xie C, Hoffmann H, Zimner-Rapuch S, Torcello-Gmez A, Stefanski A